Novo Ventures (Novo Holdings Venture Investments)

Novo Holdings Venture Investments is one of the largest and most active life science venture investors globally, providing capital, knowledge, and a network to companies in the biotechnology and medical technology sectors — spanning early-stage, translatable science through commercial-stage products. The team primarily invests in companies developing innovative drugs and novel technologies, typically leading or co-leading private rounds with active board participation, while also investing in publicly traded equities. Backed by Novo Holdings' evergreen structure and connection to the Novo Nordisk Foundation, the team takes a long-term view to advance science and medicine for the benefit of society, deploying approximately $500–750 million annually across the US, Europe, and Asia from offices in San Francisco, Boston, London, and Copenhagen.